Jane Street’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.2K Buy
19,200
+7,500
+64% +$25.1K ﹤0.01% 10991
2025
Q4
$46.6K Buy
+11,700
New +$51.8K ﹤0.01% 10526
2022
Q1
Sell
-15,200
Closed -$720K 10642
2021
Q4
$720K Buy
15,200
+1,400
+10% +$84K ﹤0.01% 6581
2021
Q3
$1M Buy
+13,800
New +$998K ﹤0.01% 5902

Other funds holding NBP

Jane Street's NBP Position: Q1 2026 in Review

Jane Street sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 32,581 shares — an estimated $109K sold.

Jane Street first reported a position in NBP in Q4 2020 and held it in 9 quarters. The position peaked at $11.1M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Jane Street reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 32,581 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $109K.
  • Jane Street first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 9 quarters.
  • Jane Street's NovaBridge Biosciences American Depositary Shares position peaked at $11.1M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.